期刊
MEDICAL MYCOLOGY
卷 54, 期 1, 页码 1-22出版社
OXFORD UNIV PRESS
DOI: 10.1093/mmy/myv076
关键词
Candida; antifungal stewardship; rapid diagnostic test; resistance
资金
- Astellas
- Merck
- Methylgene
- Pfizer
- Seachaid
- Synexis
- Cidara
- Achaogen
- Actelion
- Affinium
- American Proficiency Institute (API)
- AmpliPhi Bio
- Anacor
- AstraZenica
- Basilea
- BioVersys
- Cardeas
- Cempra
- Cerexa
- Cubist
- Daiichi
- Dipexium
- Durata
- Fedora
- Forrest Research Institute
- Furiex
- Genetech
- GlaxoSmithKline
- Janssen
- Johnson Johnson
- Medpace
- Meiji Seika Kaisha
- Melinta
- Nabriva
- Nanosphere
- Novartis
- Polyphor
- Remplex
- Roche
- Shionogi
- Synthes
- Medicines Co.
- Theravance
- ThermoFisher
- Venatorx
- Vertex
- Waterloo
Candidemia and other forms of candidiasis are associated with considerable excess mortality and costs. Despite the addition of several new antifungal agents with improved spectrum and potency, the frequency of Candida infection and associated mortality have not decreased in the past two decades. The lack of rapid and sensitive diagnostic tests has led to considerable overuse of antifungal agents resulting in increased costs, selection pressure for resistance, unnecessary drug toxicity, and adverse drug interactions. Both the lack of timely diagnostic tests and emergence of antifungal resistance pose considerable problems for antifungal stewardship. Whereas antifungal stewardship with a focus on nosocomial candidiasis should be able to improve the administration of antifungal therapy in terms of drug selection, proper dose and duration, source control and de-escalation therapy, an important parameter, timeliness of antifungal therapy, remains a victim of slow and insensitive diagnostic tests. Fortunately, new proteomic and molecular diagnostic tools are improving the time to species identification and detection. In this review we will describe the potential impact that rapid diagnostic testing and antifungal stewardship can have on the management of nosocomial candidiasis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据